BTC $79,329.03 -0.60%
ETH $2,495.42 +0.21%
BNB $741.63 -0.99%
XRP $1.40 -0.64%
SOL $104.34 -1.09%
TRX $0.3345 -0.15%
DOGE $0.0903 +0.95%
ADA $0.2208 +0.98%
BCH $262.14 +2.32%
LINK $12.81 +3.82%
HYPE $85.40 -2.18%
AAVE $132.47 -0.17%
SUI $0.8290 +4.19%
XLM $0.1927 +5.06%
ZEC $1,165.20 -4.21%
BTC $79,329.03 -0.60%
ETH $2,495.42 +0.21%
BNB $741.63 -0.99%
XRP $1.40 -0.64%
SOL $104.34 -1.09%
TRX $0.3345 -0.15%
DOGE $0.0903 +0.95%
ADA $0.2208 +0.98%
BCH $262.14 +2.32%
LINK $12.81 +3.82%
HYPE $85.40 -2.18%
AAVE $132.47 -0.17%
SUI $0.8290 +4.19%
XLM $0.1927 +5.06%
ZEC $1,165.20 -4.21%

彭博社:Arthur Hayes 近期重金投資某人類壽命延長公司,過去 1 年定期接受幹細胞靜脈輸注治療

2025-08-21 09:43:07

ChainCatcher 消息,据彭博社報導,BitMEX 聯合創始人 Arthur Hayes 正將投資目光轉向人類壽命延長領域,其近期重金投資了一家在墨西哥和曼谷設有診所的幹細胞企業,並加入其董事會。

過去一年他定期乘機前往接受靜脈輸注治療,直言"希望儘可能健康地延長壽命"。儘管因品牌重塑暫未透露公司名稱,但他強調:這是未來趨勢------越來越多國家正放寬幹細胞使用法規。

app_icon
ChainCatcher 與創新者共建Web3世界